Essence Investment Acquires AMP Alternative Medical Products GmbH

ZUG, Switzerland –

Essence Investment AG (“Essence” or the “Company”), a leading Swiss holding supporting the growth of the European cannabis industry, today announced the acquisition on 30 December 2022 of a 100% stake in AMP Alternative Medical Products GmbH (“AMP”), a German-licensed importer and distributor of EU-GMP medical cannabis products.

In addition to valuing AMP’s intrinsic investment potential, Essence anticipates that its Swiss-based portfolio companies, Marry Jane AG, and Swiss Extract AG, will benefit from AMP’s distribution capacity in Germany’s large and growing medical cannabis market.

Henricus J. Stander III, a Member of the Board of Directors of Essence, commented, “AMP’s people are first-rate and have built trusted, strong relationships with key German distributors and pharmacies, as well as leading suppliers of medical cannabis from Canada, Netherlands and Denmark. The Swiss-grown product of Marry Jane and Swiss Extract represents the highest quality and will strengthen AMP’s competitiveness, bringing greater choice to German patients.”

Dr. Stefan Feuerstein, Managing Director of AMP, observed, “The indoor cultivation and manufacturing facilities Essence has financed in Switzerland are quality benchmarks for Europe.  Marry Jane and Swiss Extract will provide superior medicine at a consistency and scale that is difficult to match.” He added, “With Essence as our shareholder and partner in our expanding portfolio of offerings, we can source more efficiently at a greater scale and better serve German patients, bringing them fresh products featuring a range of rich terpene and cannabis profiles.”

About Essence Investment AG

Essence Investment AG is a Swiss holding dedicated to providing the highest-quality cannabis products to European patients and consumers. Its principal Swiss assets are: Marry Jane AG, Breitenbach – the largest indoor producer of premium CBD flowers in Europe (circa 15 tonnes in 2022); and Swiss Extract AG – a greenhouse cultivator and BioSuisse-certified producer of premium cannabis extracts for its own brand and white-label supplier to a number of European CBD companies.

About AMP Alternative Medical Products GmbH

AMP Alternative Medical Products GmbH is licensed to import European Union – Good Manufacturing Practice (EU-GMP) medical cannabis and sell to pharmaceutical distributors or pharmacists directly, the only point-of-sale for medical cannabis to German patients.

Importing high-quality medical cannabis from the Netherlands, Canada and Denmark, AMP at present is supplying roughly 150 pharmacies throughout the country, including Germany`s leading cannabis-dispensing pharmacies.



Comments

Post a Comment

Popular posts from this blog

8 Breeders and Seed Banks with Desirable Strains for 2024

Every cannabis grower hopes to have a plentiful harvest full of top-shelf buds. One of the best ways to meet that goal is by planting quality genetics . But with so many breeders out there, it may be difficult to determine the best cannabis seed banks for your needs. Cannabis seeds are technically legal across the United States since they contain less than 0.3 percent THC, according to the 2018 Farm Bill. In the last six years, dozens of online seed banks have popped up vying for market share. Offering feminized cannabis seeds and autoflowering seeds in many of the most popular strains , there are endless genetics from which to choose. The best cannabis seeds for an operator may vary depending on whether a grow is indoors or outdoors, their preferred growing medium, and the ultimate goal for the crop. For example, are you hoping to extract rosin or sell smokable buds? These questions must be considered prior to selecting marijuana strains and, by proxy, a source for those genetics....
Read more

Audacious Awarded New Jersey Adult Use Licenses

LAS VEGAS – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) “AUSA”, “AUDACIOUS”, or the “Company), today announced the Company was awarded a provisional Cultivation license, as well as a provisional Manufacturing license in the state of New Jersey. With a population close to 9 million people, New Jersey officially announced on Thursday that adult-use marijuana sales will start on April 21. Residents in the Garden State voted to legalize recreational cannabis in 2020. Market insiders estimate the total New Jersey opportunity to approach U.S.$2 billion[1]. To date, the state has awarded 37 conditional cultivation licenses and 70 conditional manufacturing licenses, in addition to allowing 6 of the incumbent 12 medical use operators to participate. The limited number of licenses awarded and the limited availability of municipalities that have opted in provides AUDACIOUS with a significant early mover advantage. Terry Booth, CEO, commented, “AUDACIOUS’ new team, just o...
Read more

Will This Be Our Year?

In 1919, a ban on alcohol exposed a cultural divide between urban and rural America and led to a spike in organized crime. Federal, state, and local governments struggled to adapt to the abrupt change in reality that came to be known as Prohibition. The task of enforcing new regulations initially fell to the Internal Revenue Service (thus the term “revenuers” for federal agents who hunted moonshiners) before being passed to the Department of Justice (DOJ). While enforcement was concentrated in rural areas and small towns—where some folks made decent livings by operating homemade stills—urban dwellers continued to enjoy alcohol courtesy of bootleggers and speakeasies. With the end of Prohibition in 1933, after the broken bottles, blood, and dust finally settled, an article in The United States News (now U.S. News & World Report) attempted to give the citizenry an idea of how the path forward might look. The open season for liquor-control laws is at hand. With repeal on December ...
Read more